Hormone replacement therapy and risks of various cancers in postmenopausal women with de novo or a history of endometriosis

In: Proceedings of the 39th Annual Meeting of the Korean Society of Gynecologic Oncology · 2024 · pp. U2 · doi:10.3802/jgo.2024.35.s2.fp-u2 · W4399505902
article OA: gold CC0
AI-generated summary by qwen3.7-flash, 2026-08-25

This paper investigates the risks of various cancers associated with hormone replacement therapy in postmenopausal women who have de novo endometriosis or a history of the condition.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK